
Archive
84 Posts


Spending $2 Billion on Alzheimer’s: a Fantasy

Eisai-Biogen BAN2401: was I wrong to like the trial last year [Dec 2017] ??

Bill Gates’ $30M for Alz Diagnostics [Jul 2018]: hmmmm….

Bill Gates’ $50M for Alz research [Nov 2017]: wish list!

Alzheimer’s clinical research lacks leadership [headline by Balt Sun, Op-Ed Apr 2017]

Solanezumab trial NEJM [Jan 2018]: What was learned for moving forward?

Dementia patients want effective drugs… [lowering expectations? RE: FDA Feb 2018, on KevinMD.com, May 2018]

Resilience until age 90 despite concussions/ head traumas [15′ daily exercise? Jul 2018]
